Treatment effect variability in brain stimulation across psychiatric disorders: A meta-analysis of variance.
Bipolar disorder
Heterogeneity in treatment response
Noninvasive brain stimulation
Obsessive–compulsive disorder
Personalized treatment
Schizophrenia spectrum disorder
Transcranial direct current stimulation
Transcranial magnetic stimulation
Unipolar and bipolar depression
Journal
Neuroscience and biobehavioral reviews
ISSN: 1873-7528
Titre abrégé: Neurosci Biobehav Rev
Pays: United States
ID NLM: 7806090
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
08
06
2020
revised:
26
10
2020
accepted:
29
11
2020
pubmed:
23
1
2021
medline:
29
6
2021
entrez:
22
1
2021
Statut:
ppublish
Résumé
Noninvasive brain stimulation methods such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) are promising add-on treatments for a number of psychiatric conditions. Yet, some of the initial excitement is wearing off. Randomized controlled trials (RCT) have found inconsistent results. This inconsistency is suspected to be the consequence of variation in treatment effects and solvable by identifying responders in RCTs and individualizing treatment. However, is there enough evidence from RCTs that patients respond differently to treatment? This question can be addressed by comparing the variability in the active stimulation group with the variability in the sham group. We searched MEDLINE/PubMed and included all double-blinded, sham-controlled RCTs and crossover trials that used TMS or tDCS in adults with a unipolar or bipolar depression, bipolar disorder, schizophrenia spectrum disorder, or obsessive compulsive disorder. In accordance with the PRISMA guidelines to ensure data quality and validity, we extracted a measure of variability of the primary outcome. A total of 130 studies with 5748 patients were considered in the analysis. We calculated variance-weighted variability ratios for each comparison of active stimulation vs sham and entered them into a random-effects model. We hypothesized that treatment effect variability in TMS or tDCS would be reflected by increased variability after active compared with sham stimulation, or in other words, a variability ratio greater than one. Across diagnoses, we found only a minimal increase in variability after active stimulation compared with sham that did not reach statistical significance (variability ratio = 1.03; 95% CI, 0.97, 1.08, P = 0.358). In conclusion, this study found little evidence for treatment effect variability in brain stimulation, suggesting that the need for personalized or stratified medicine is still an open question.
Identifiants
pubmed: 33482243
pii: S0149-7634(20)30676-X
doi: 10.1016/j.neubiorev.2020.11.033
pii:
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
54-62Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.